2020
DOI: 10.3390/pharmaceutics12121187
|View full text |Cite
|
Sign up to set email alerts
|

Clinical Pharmacokinetic Evaluation of Optimized Liquisolid Tablets as a Potential Therapy for Male Sexual Dysfunction

Abstract: The study aimed at developing a liquisolid tablet (LST) containing tadalafil (TDL) and dapoxetine (DPX) with improved bioavailability as a potential therapy for male sexual dysfunction. A mixture of nonvolatile solvents, namely PEG 200 and Labrasol®, was utilized to prepare LSTs that were assessed for their quality characteristics. The Box–Behnken design (BBD) was employed to statistically explore the effect of the formulation factors on the quality attributes of LSTs. Furthermore, an in vivo pharmacokinetic s… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(1 citation statement)
references
References 62 publications
0
1
0
Order By: Relevance
“…The concept of liquisolid tablets was developed initially from powdered solution technology that can be used to formulate liquid medication. A liquisolid system is defined as dry, non-adherent, free-flowing and compressible powder mixtures converted from liquid drugs, drug suspensions or drug solutions in nonvolatile solvents with selected carriers and coating materials [7][8][9]. In this technique, the drug is dissolved in a non-volatile solvent and converted into a dry, free flowing, and compressible solid using carrier and coating materials.…”
Section: Introductionmentioning
confidence: 99%
“…The concept of liquisolid tablets was developed initially from powdered solution technology that can be used to formulate liquid medication. A liquisolid system is defined as dry, non-adherent, free-flowing and compressible powder mixtures converted from liquid drugs, drug suspensions or drug solutions in nonvolatile solvents with selected carriers and coating materials [7][8][9]. In this technique, the drug is dissolved in a non-volatile solvent and converted into a dry, free flowing, and compressible solid using carrier and coating materials.…”
Section: Introductionmentioning
confidence: 99%